That's a fair point, but that's not what I'm asking. There is a process to add pharmaceuticals to the list, and it may be cumbersome or it may not be. But my question is more that Industry Canada stated that if you did not have schedules, you would in fact make the process longer by having litigation over patents between the generics and the brand names.
You're stating that is not your position. Why not?